Maharashtra Expands International Ties in Pharma and Nutraceuticals at Suite Sumflex 2026
Maharashtra's recent investment forum, Suite Sumflex 2026, attracted over 150 leaders from 25 countries, focusing on partnerships in nutraceuticals, pharmaceuticals, and logistics. The event underscores Maharashtra's proactive approach to economic diplomacy, enhancing its role in Central Asia's emerging pharma market.
Theia Market Signal Identification - AI Assisted
Maharashtra's investment outreach intensified at Suite Sumflex 2026, drawing C-suite executives from over 25 countries including Uzbekistan and the USA. Key engagements included discussions on pharmaceutical trade with Uzbekistan's health sector, involving potential cooperation on technology transfer and market access.
Dr. Rajesh Gawande led dialogues on algae-based carbon capture and e-commerce logistics, emphasizing Maharashtra's strategic infrastructure. The forum highlighted the region's growing significance in the global nutraceutical landscape, with possible future agreements in logistics and sustainability. The proactive investment strategy aims to solidify Maharashtra's position as a hub for regional expansion in pharmaceuticals and nutraceuticals.
Comments